معرفی
Dr. Chris Smedley is a Research Fellow in Medicinal Chemistry at Monash University, affiliated with the Monash Institute of Pharmaceutical Sciences (MIPS). Since joining MIPS in 2020, he has contributed to an ARC Discovery grant program focused on developing biased bitopic ligands targeting the A1 adenosine receptor for cardioprotection, as well as novel A2BR agonists and A1R positive allosteric modulators.
- PhD in Organic and Medicinal Chemistry, La Trobe University (2018)
- MSci in Medicinal and Biological Chemistry, University of Nottingham (2013)
- Postdoctoral Research Associate, La Trobe University (2018–2020)
His research centers on innovative synthetic methodologies in click chemistry, particularly Sulfur Fluoride Exchange (SuFEx) and his conceived concept of Diversity Oriented Clicking, enabling rapid assembly of complex molecular architectures. He has developed new SuFEx hubs and amide coupling methods for challenging substrates, advancing the field of modular synthesis.
His recent publications demonstrate a strong trend in developing catalytic, multidimensional click reactions (e.g., phosphorus fluoride exchange), synthesizing bioactive compounds, and creating novel sulfonyl fluoride-based building blocks. These works span high-impact journals like Angewandte Chemie and Chem, reflecting a focus on synthetic innovation with applications in drug discovery.
Dr. Smedley has been recognized with prestigious awards:
- Marie Skłodowska-Curie Rise Award (2015)
- Nancy Millis Medal (2018)
He is the Primary Chief Investigator on an active ARC Discovery Project (2024–2026) titled "Diversity Oriented Clicking - Streamlined Synthesis of Molecular Frameworks," indicating leadership in independent research. While no formal advisees are listed, his collaborative output suggests active mentoring and team-based research. His work contributes to UN Sustainable Development Goals, particularly through advancements in medicinal science and education.
Dr. Smedley conducts his research within the Monash Institute of Pharmaceutical Sciences, a leading hub for drug discovery and pharmaceutical innovation, where he continues to expand the frontiers of click chemistry and its biomedical applications.
